Skip to main content

Aptivus

Generic: tipranavir

Verified·Apr 23, 2026
Manufacturer
Boehringer Ingelheim
NDC
0597-0003
RxCUI
577212
Route
ORAL
ICD-10 indication
B20

Affordability Check

How much will you actually pay for Aptivus?

In 30 seconds, see every legitimate way to afford Aptivus — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Aptivus

What is this medication?

Aptivus is a prescription medicine used in combination with ritonavir to treat human immunodeficiency virus type 1, which is commonly known as HIV-1. It belongs to a class of medications called protease inhibitors and is typically prescribed for adults and children at least two years old who have already tried other antiretroviral treatments. This drug is often reserved for patients whose virus has become resistant to other protease inhibitors, as it works by blocking the enzyme that the virus needs to replicate and spread throughout the body.

While Aptivus helps to lower the viral load in the blood and can improve the count of immune cells, it is not a cure for HIV or AIDS. It must be taken exactly as directed by a healthcare professional and always alongside a low dose of ritonavir to be effective. Because the medication can interact with many other drugs and carries risks of serious side effects like liver damage or intracranial hemorrhage, patients must undergo regular medical testing and monitoring while they are on this treatment regimen.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Aptivus appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-07-31).

Covered by plans

68%

3,706 of 5,490 plans

Most common tier

Tier 5

On 79% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)59
18%
Tier 2 (generic)2
1%
Tier 4 (non-preferred brand)8
2%
Tier 5 (specialty)257
79%
Tier 61
0%

Step therapy: 0% of formularies

Quantity limits: 47% of formularies

Coverage breadth: 327 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.